MG Therapies
An EvoNexus Incubator Company
MG Therapies delivers cost effective, efficacious treatments for Dry Eye Syndrome (DES) and Meibomian Gland Dysfuction. The MGrx is an in-clinic table top device that delivers three clinical treatments (Lid Debridement, Gland Expression, Anti-inflammatory Cold Therapy) effectively and at 1/4 the cost of the market leader.